Correlation Between Abcellera Biologics and 191216DE7

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and 191216DE7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and 191216DE7 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and COCA COLA CO, you can compare the effects of market volatilities on Abcellera Biologics and 191216DE7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of 191216DE7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and 191216DE7.

Diversification Opportunities for Abcellera Biologics and 191216DE7

-0.52

Correlation Coefficient

Abcellera Biologics  191216DE7

Excellent diversification

The 3 months correlation between Abcellera and 191216DE7 is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and COCA COLA CO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COCA A CO and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with 191216DE7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COCA A CO has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and 191216DE7 go up and down completely randomly.

Pair Corralation between Abcellera Biologics and 191216DE7

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 4.24 times more return on investment than 191216DE7. However, Abcellera Biologics is 4.24 times more volatile than COCA COLA CO. It trades about 0.11 of its potential returns per unit of risk. COCA COLA CO is currently generating about -0.16 per unit of risk. If you would invest  295.00  in Abcellera Biologics on October 8, 2024 and sell it today you would earn a total of  18.00  from holding Abcellera Biologics or generate 6.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.0%
Values	Daily Returns

Abcellera Biologics  vs.  COCA COLA CO

Abcellera Biologics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

COCA A CO

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days COCA COLA CO has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 191216DE7 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Abcellera Biologics and 191216DE7

The main advantage of trading using opposite Abcellera Biologics and 191216DE7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, 191216DE7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 191216DE7 will offset losses from the drop in 191216DE7's long position.

The idea behind Abcellera Biologics and COCA COLA CO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.